Akt Inhibitor MK2206 in Treating Patients With Recurrent or Advanced Endometrial Cancer

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT01307631
First received: March 1, 2011
Last updated: June 14, 2016
Last verified: June 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Primary Completion Date: January 2016 (Final data collection date for primary outcome measure)